By 1812Blockhouse
Residents across north central Ohio will have an opportunity to access reduced-cost blood screenings throughout April, as Avita Health System rolls out its annual community testing program.
The screenings are available from April 1 through April 30, and include a range of common lab tests designed to provide a snapshot of overall health.
What’s Available
Participants can purchase vouchers for the following screenings:
- HealthLink Lab Profile — $30
(Includes lipids, chemistry panel, and complete blood count) - PSA — $25
(Prostate-specific antigen test) - HgbA1c — $30
(Measures average blood sugar levels) - TSH — $15
(Thyroid function test) - Vitamin D, 25 — $30
How It Works
Vouchers must be purchased between April 1 and April 30 at the following locations:
- Cashier’s office at Galion Hospital
- Registration desks at Bucyrus and Ontario hospitals
- Bellville and Shelby Walk-In Clinics
Vouchers cannot be purchased at Ontario South Campus or the Ontario Walk-In Clinic. Once purchased, vouchers may be redeemed during April at:
- Any Avita hospital
- Ontario South Campus lab
- Bellville or Shelby Walk-In Clinics
Same-day purchase and testing is allowed, provided preparation requirements are met. All vouchers expire April 30.
Lab Hours
Bucyrus and Galion
- Monday–Friday: 6:00 AM to 5:00 PM
- Saturday: 7:00 AM to Noon
- Sunday: Closed
Ontario
- Monday–Friday: 6:00 AM to 8:00 PM
- Saturday: 7:00 AM to Noon
- Sunday: Closed
Ontario South Campus Lab
- Monday–Friday: 6:00 AM to 6:00 PM
- Saturday–Sunday: Closed
Bellville and Shelby Walk-In Clinics
- Daily: 8:00 AM to 8:00 PM
Important Notes
- Results will be mailed directly to participants
- Physicians will not automatically receive results
- Patients are responsible for sharing results with their provider
This is a straightforward, low-cost way for residents to check key health indicators without going through a traditional office visit. For many, it’s an accessible entry point into preventive care — especially for conditions like diabetes, thyroid disorders, and cardiovascular risk.
